The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP opened new calls for research proposals under its second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.
EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 13 African and 13 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.
Find out more about who we are!
EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.
EDCTP2 work plan for 2014 now available online
The first annual work plan of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2) describes…
PanACEA MAMS-TB-01 trial: ‘high-dose rifampicin may help shorten TB treatment’
Published 26 February 2015